Related Experiment Videos
Immunological mechanisms operative in allergen-specific immunotherapy
1Institute of General and Experimental Pathology, University of Vienna, Austria.
International Archives of Allergy and Immunology
|May 26, 1999
Summary
Specific immunotherapy (SIT) reduces allergy symptoms by administering increasing allergen doses. While effective, the exact immunological mechanisms behind successful SIT remain under investigation.
Area of Science:
- Immunology
- Allergy Research
- Clinical Medicine
Background:
- Specific immunotherapy (SIT) involves administering increasing doses of allergen extracts to individuals with IgE-mediated hypersensitivity.
- Also known as hyposensitization or desensitization, SIT aims to reduce allergic symptom severity upon allergen exposure.
- Despite over 80 years of empirical use for type I allergies and venom hypersensitivity, the precise immunological mechanisms require further elucidation.
Purpose of the Study:
- To review recent research characterizing the immunological events associated with successful specific immunotherapy.
- To provide insight into the mechanisms driving therapeutic effects in SIT.
Main Methods:
- Review of current literature on immunological mechanisms in specific immunotherapy.
- Analysis of studies investigating cellular and molecular changes during SIT.
Main Results:
- Established efficacy of SIT through double-blind, placebo-controlled studies.
- Ongoing research aims to fully elucidate the complex immunological pathways involved in SIT success.
- Identified key immunological events and changes occurring during the treatment process.
Conclusions:
- Specific immunotherapy is a proven therapeutic option for type I allergies and venom hypersensitivity.
- Further research into the immunological underpinnings of SIT is crucial for optimizing treatment strategies.
- Understanding these mechanisms will enhance the effectiveness and application of SIT.